Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Andrew Gwynne on 2016-03-01.

To ask the Secretary of State for Health, with reference to page 15 of the interim report of the Accelerated Access Review, published October 2014, what recent discussions he has had on the implementation of new models of pricing and reimbursing drugs; when he anticipates implementing such new models; what discussions he has had with (a) his Department’s officials and (b) external organisations on the applicability of such models to drugs targeting the genetically validated target PCSK9; and if he will make a statement.

George Freeman

The Accelerated Access Review, chaired by Sir Hugh Taylor, will make recommendations to government on reforms to accelerate access for National Health Service patients to innovative medicines and medical technologies making our country the best place in the world to design, develop and deploy these products. The terms of the reference for the review focus on faster access to innovations, which may include drugs that target genetically validated targets such as PCSK9 and BCL2.